Anzu Special Acquisition Corp I
Status: Closed Deal
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $425.00M |
|---|---|
| IPO Date | Mar 2, 2021 |
| CEO | Dr. Whitney Haring-Smith |
| Left Lead | BofA Securities |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24+6 |
| IPO Sector | Industrial ▶ |
| IPO Geography | Global |
| Target Company | Envoy Medical |
| Deal Announced | Apr 18, 2023 |
| Deal Size, $M | $150.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Sep 27, 2023 |
| Amendment Vote | Sep 29, 2023 |
| Closing Date | Sep 29, 2023 |
Formerly ANZU
COCH
COCHW
| Price | $1.50 |
|---|---|
| Last closing price | $1.40 |
| H/L, today | $1.40 / $1.63 |
| H/L, 52-week | $1.02 / $5.55 |
| Volume, today | 15,694 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.